A Rare Cause Leading to the Cloudy Peritoneal Dialysate: Lercanidipine

References (8)

1. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A et al. International Society for Peritoneal Dialysis. recommendations: 2010 update. Perit Dial Int 2010;30:393-423. infections Hutchison AJ, Vardhan A. Peritoneal dialysis. In: Greenberg A ed. Primer on kidney diseases. 5th ed. Philadelphia: Saunders Elselvier; 2009, p. 459-71.
2. Alçelik A, Bicik Z, Albayrak S, Çalışkan Ş. Periton diyalizat sıvısının ısıtılmadan kullanımına bağlı şimik peritonit: Olgu sunumu. Turk Neph Dial Transpl 2005;14:42-4.
3. Topal C, Sayarlioglu H, Dogan E, Erkoç R, Soyoral Y. Cloudy dialysate due to lercanidipine. Nephrol Dial Transplant 2006;21:2997-8.
4. Yang WS, Huang JW, Chen HW, Tsai TJ, Wu KD. Lercanidipine-induced chyloperitoneum in patients on peritoneal dialysis. Perit Dial Int. 2008;28:632-6.
5. Lal SM, Nolph KD, Moore HL, Khanna R. Effects of calcium channel blockers (verapamil, diltiazem) on peritoneal transport. ASAIO Trans 1986;32:564-6.
6. Favazza A, Motanaro D, Messa P, Antonucci F, Gropuzzo M, Mioni G. Peritoneal clearances in hypertensive CAPD patients after oral administration of clonidine, enalapril, and nifedipine. Perit Dial Int 1992;12:287-91.
7. Rojas-Campos E, Cortes-Sanabria L, Martinez-Ramirez HR, Gonzalez L, Martin-del-Campo F, Gonzalez-Ortiz M, et al. Effect of oral administration of losartan, prazosin, and verapamil on peritoneal solute transport in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2005;25:576-82.
8. Suzuki H, Inoue T, Kobayashi K, Shoda J, Nakamoto H. The newly developed calcium antagonist, azelnidipine, increases drain volume in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2006;22:18-23